Video Gallery

What is Immunotherapy?

Drew Pardoll, M.D., Ph.D., Director of the Bloomberg~Kimmel Institute for Cancer Immunotherapy and the Co-Director of the Cancer Immunology Program at the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center explains what is immunotherapy and how it is changing cure rates for cancer patients.

Death to Life with Immunotherapy: Stefanie's Story

Metastatic colon cancer patient, Stefanie tells her success story with immunotherapy and how it saved her life.

Dr. Elizabeth Jaffee

Dr. Elizabeth Jaffee, associate-director of The Bloomberg~Kimmel Institute for Cancer Immunotherapy at The Johns Hopkins Kimmel Cancer Center explains immune therapy.

Immunotherapy - Game Changer, Game Challenge

Drs. Victor Velculescu and Julie Brahmer of The Bloomberg~Kimmel Institute for Cancer Immunotherapy at the Johns Hopkins Kimmel Cancer Center discuss why immune therapy is both effective and challenging.

The Immune System: A Powerful Anticancer Agent

Richard Jones, M.D., Director of the Bone Marrow Transplant Program and Co-Director, Hematologic Malignancies Program of the Johns Hopkins Kimmel Cancer Center explains immunotherapy and bone marrow transplants and how innovation is a game changer.

Immunotherapy and Melanoma

Suzanne Topalian., Associate Director, Bloomberg~Kimmel Institute for Cancer Immunotherapy, Director, Melanoma Program at The Johns Hopkins Kimmel Cancer Center explains immunotherapy and melanoma and the immune checkpoints that are helping to create new treatments.

Immunotherapy and the Microbiome

Suzanne Topalian., Associate Director, Bloomberg~Kimmel Institute for Cancer Immunotherapy, Director, Melanoma Program at The Johns Hopkins Kimmel Cancer Center explains immunotherapy and melanoma and the immune checkpoints that are helping to create new treatments.

Immunotherapy - Moving Forward

Leisha Emens, team member of The Bloomberg~Kimmel Institute for Cancer Immunotherapy, is working to move the science of immunotherapy forward, where the responses are faster and longer lasting.

Dr. Jonathan Powell

Dr. Jonathan Powell, associate-director of The Bloomberg~Kimmel Institute for Cancer Immunotherapy at The Johns Hopkins Kimmel Cancer Center explains immune therapy and how it is used to treat many types of cancers.

Dr. Ivan Borrello

Dr. Ivan Borrello, associate professor of oncology at The Johns Hopkins Kimmel Cancer Center and Bloomberg~Kimmel Institute Cancer Immunologist, explains immune and T cell therapy, specifically MILS.

Promise and Progress at the Bloomberg~Kimmel Institute for Cancer Immunotherapy

A Special Program of Research: Promise and Progress at the Bloomberg~Kimmel Institute for Cancer Immunotherapy